Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors

NCT06162663 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Failure to reach study enrollment milestones

Conditions

Breast Cancer
Insomnia

Interventions

DRUG: Suvorexant Tablets
OTHER: Placebo Control

Sponsor

Medical University of South Carolina

Collaborators

[object Object]